Based upon our analysis of current events, reasonably foreseeable trends in the pharma industry, as well as our overall collective experiences, BusStim identified a void and/or gap in the traditional drug development model. To address this problem BusStim created a new business model opportunistically fills the void in the traditional drug delivery model, to create a seamless partnership between Big Pharma and the BioTech community, thereby successfully meeting the needs of both parties.